These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6405846)

  • 1. Platelet count: a simple measure of activity in Crohn's disease.
    Harries AD; Fitzsimons E; Fifield R; Dew MJ; Rhoades J
    Br Med J (Clin Res Ed); 1983 May; 286(6376):1476. PubMed ID: 6405846
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet number and size in relation to serum orosomucoid concentration in Crohn's disease.
    Shah A; Morgan G; Rose JD; Fifield R; Rhodes J
    Med Lab Sci; 1989 Jan; 46(1):79-80. PubMed ID: 2779388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet count in patients with Crohn's disease.
    Br Med J (Clin Res Ed); 1983 Jun; 286(6381):1895-6. PubMed ID: 6407620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of the ratio of orosomucoid and prealbumin values as an indicator of the activity of Crohn's disease].
    Richter J; Bitter J; Král V; Zuvacová J
    Cas Lek Cesk; 1982 Dec; 121(48):1493-4. PubMed ID: 7151117
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in Crohn's disease: The controversy remains.
    Bou Jaoude J; Bakouny Z; Hallit R; Honein K; Ghorra C; El Rassy E
    Clin Res Hepatol Gastroenterol; 2018 Feb; 42(1):e16-e18. PubMed ID: 28797908
    [No Abstract]   [Full Text] [Related]  

  • 6. The acute phase protein response in Crohn's colitis.
    Winslet MC; Sherwell J; Radley S; Keighley MR
    Biochem Soc Trans; 1991 Apr; 19(2):222S. PubMed ID: 1716225
    [No Abstract]   [Full Text] [Related]  

  • 7. Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.
    Crabtree JE; Juby LD; Heatley RV; Lobo AJ; Bullimore DW; Axon AT
    Gut; 1990 Sep; 31(9):1033-6. PubMed ID: 2210449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
    Feagan BG; Rochon J; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Gillies R; Hopkins M
    N Engl J Med; 1995 Feb; 332(5):292-7. PubMed ID: 7816064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index.
    Andre C; Descos L; Landais P; Fermanian J
    Gut; 1981 Jul; 22(7):571-4. PubMed ID: 6973509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocytes as an indicator of activity in Crohn's disease treated with total parenteral and/or enteral nutrition].
    Bures J; Horácek J; Pecka M; Tichý M; Cervenka B; Král B; Fixa B; Komárková O; Pidrman V
    Vnitr Lek; 1994 Feb; 40(2):84-8. PubMed ID: 8140766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mean platelet volume (MPV) in Crohn's disease patients].
    Douda T; Bures J; Rejchrt S; Kopácová M; Pecka M; Malý J
    Cas Lek Cesk; 2006; 145(11):870-3. PubMed ID: 17168422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total parenteral nutrition modifies the acute phase response to Crohn's disease.
    Carlson GL; Gray P; Barber D; Shaffer JL; Mughal M; Irving MH
    J R Coll Surg Edinb; 1994 Dec; 39(6):360-4. PubMed ID: 7532715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
    Cellier C; Sahmoud T; Froguel E; Adenis A; Belaiche J; Bretagne JF; Florent C; Bouvry M; Mary JY; Modigliani R
    Gut; 1994 Feb; 35(2):231-5. PubMed ID: 7508411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Applicability and indications of colonoscopic screening for Crohn's disease in patients with fistula-in-ano].
    Chen X; He X; Zou Y; Lan P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):1030-1034. PubMed ID: 27680073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood protein concentrations--are they parameters of disease activity in Crohn's disease?].
    Meryn S; Lochs H; Bettelheim P; Sertl K; Mulak K
    Leber Magen Darm; 1985 Jul; 15(4):160-4. PubMed ID: 3877229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic thrombocytopenic purpura associated with Crohn's disease.
    Baudard M; Molina T; Benfiguig K; Bethoux JP; Zittoun R
    Haematologica; 1998 Jan; 83(1):92-3. PubMed ID: 9542329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First successful use of leukocyte apheresis as maintenance therapy for Crohn's disease in the United Kingdom.
    Tate D; Cairnes V; Valori R; Makins R
    J Clin Apher; 2014 Jun; 29(3):181-2. PubMed ID: 24243700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet kinetics in Crohn's disease.
    Bremer G; Jacobi E; Miller B; Ehms H; Strohmeyer G
    Klin Wochenschr; 1978 Apr; 56(7):365-7. PubMed ID: 642410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral indices of disease activity in inflammatory bowel disease.
    Koldkjaer O; Klitgaard NA; Schmidt KG
    Digestion; 1978; 17(5):387-95. PubMed ID: 680416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.